MDK and lung adenocarcinoma: MDK is also known to activate ERK (a MAPK) in normal non-tumorigenic cells [16], [28]; however, ERK and p38MAPK were not inhibited by iMDK in H441 lung adenocarcinoma cells (Figure S3).